Infection with hepatitis GB virus C in patients on maintenance hemodialysis

New England Journal of Medicine

Volumn 334, Issue 23, 1996, Pages 1485-1490

  Masuko, Kazuo ^a   Mitsui, Takehiro ^a   Iwano, Keiko ^a   Yamazaki, Chikao ^a   Okuda, Kenji ^b   Meguro, Teruo ^c   Murayama, Naoki ^d   Inoue, Taisuke ^e   Tsuda, Fumio ^f   Okamoto, Hiroaki ^g   Miyakawa, Yuzo ^h   Mayumi, Makoto ^g  

^a Masuko Memorial Hospital   (Japan)

^b Okuda Clinic   (Japan)

^c Meguro Clinic   (Japan)

^d Murayama Hospital   (Japan)

^e UNIVERSITY OF YAMANASHI   (Japan)

^f Shinagawa ku   (Japan)

^g JICHI MEDICAL UNIVERSITY   (Japan)

^h Miyakawa Memorial Research Foundation   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HEPATITIS C VIRUS; HEPATITIS VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS DETECTION; VIRUS HEPATITIS;

ADULT; AGED; BASE SEQUENCE; BLOOD TRANSFUSION; DNA, COMPLEMENTARY; DNA, VIRAL; FEMALE; FLAVIVIRIDAE; HEPATITIS VIRUSES; HEPATITIS, VIRAL, HUMAN; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RENAL DIALYSIS; RNA, VIRAL;

EID: 15844417378     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199606063342301     Document Type: Article

References (27)

1. Choo QL, Kuo G. Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-62.
2. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244: 362-4.
3. Houghton M, Weiner A, Han J, Kuo G, Choo QL. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral diseases. Hepatology 1991;14:381-8.
4. Donahue JG, Muñoz A, Ness PM, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992;327:369-73.
5. Alter HJ, Bradley DW. Non-A, non-B hepatitis unrelated to the hepatitis C virus (non-ABC). Semin Liver Dis 1995;15:110-20.
6. Deinhardt F, Holmes AW, Capps RB, Popper H. Studies on the transmission of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passages, and description of liver lesions. J Exp Med 1967;125:673-88.
7. Schaluder GG, Dawson GJ, Simons JN, et al. Molecular and serologic analysis in the transmission of the GB hepatitis agents. J Med Virol 1995;46:81-90.
8. Simons JN, Pilot-Matias TJ, Leary TP, et al. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci U S A 1995;92: 3401-5.
9. Simons JN, Leary TP, Dawson GJ, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995;1:564-9.
10. Leary TP, Muerhoff AF, Simons JN, et al. Sequence and genomic organization of GBV-C: a novel member of the Flaviviridae associated with human non-A-E hepatitis. J Med Biol 1996;48:60-7.
11. Linnen J, Wages J Jr, Zhang-Keck ZY, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996;271:505-8.
12. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995;346:1131-2.
13. Okamoto H, Okada S, Sugiyama Y, et al. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5'-noncoding region. Jpn J Exp Med 1990;60:215-22.
14. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989;339: 237-8. [Erratum, Nature 1989;339:490.]
15. Okamoto H, Mishiro S, Tokita H, Tsuda F, Miyakawa Y, Mayumi M. Super-infection of chimpanzees carrying hepatitis C virus of genotype II/1b with that of genotype III/2a or I/1a. Hepatology 1994;20: 1131-6.
16. Iizuka H, Ohmura K, Ishijima A, et al. Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg. Vox Sang 1992; 63:107-11.
17. Chan TM, Lok AS, Cheng IK, Chan RT. Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays. Hepatology 1993;17:5-8.
18. Masuko K, Okuda K, Meguro T, et al. Hepatitis C virus antibodies, viral RNA and genotypes in sera from patients on maintenance haemodialysis. J Viral Hepatitis 1994;1:65-71.
19. London WT, DiFiglia M, Sutnick AI, Blumberg BS. An epidemic of hepatitis in a chronic-hemodialysis unit: Australia antigen and differences in host response. N Engl J Med 1969;281:571-8.
20. Szmuness W, Prince AM, Grady GF, et al. Hepatitis B infection: a point-prevalence study in 15 US hemodialysis centers. JAMA 1974;227:901-6.
21. Ogata N, Alter HJ, Miller RH, Purcell RH. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci U S A 1991; 88:3392-6.
22. Okamoto H, Kojima M, Okada S, et al. Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability. Virology 1992;190:894-9.
23. Aikawa T, Sugai Y, Okamoto H. Hepatitis G infection in drug abusers with chronic hepatitis C. N Engl J Med 1996;334:195-6.
24. Goldblum SE, Reed WP. Host defenses and immunologic alterations associated with chronic hemodialysis. Ann Intern Med 1980;93:597-613.
25. Kosaka Y, Takase K, Kojima M, et al. Fulminant hepatitis B: induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen. Gastroenterology 1991;100:1087-94.
26. Liang TJ, Hasegawa K, Rimon N, Wands JR, Ben-Porath E. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med 1991;324:1705-9.
27. Sato S, Suzuki K, Akahane Y, et al. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann Intern Med 1995;122:241-8.